Last update 14 Jun 2025

Silicon phthalocyanine 4

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
EGF-Au NP-Pc 4, PC-4
Target
Action
antagonists
Mechanism
EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists)
Active Indication
Originator Organization
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC39H35N9O2Si2
InChIKeyMXKIUUUHVLFVJF-UHFFFAOYSA-N
CAS Registry135719-28-7

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Actinic KeratosisPhase 1
United States
01 Sep 2004
Bowen's DiseasePhase 1
United States
01 Sep 2004
Breast CancerPhase 1
United States
01 Aug 2001
Head and Neck NeoplasmsPhase 1
United States
01 Aug 2001
LymphomaPhase 1
United States
01 Aug 2001
Neoplasm MetastasisPhase 1
United States
01 Aug 2001
SarcomaPhase 1
United States
01 Aug 2001
Skin NeoplasmsPhase 1
United States
01 Aug 2001
GliomaPreclinical
United States
15 Apr 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
11
Photodynamic Therapy+silicon phthalocyanine 4
fnpriedepp = cyvjjcfurq ehacrwjksp (zxevsguncl, oswtypsuiw - osgbpprsds)
-
16 May 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free